Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 6/20 | 0.77 |
| ▸ | MAPT | P10636 | 4/20 | 0.76 |
| ▸ | LMNA | P02545 | 3/20 | 0.76 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | PPARG | P37231 | 2/20 | 0.67 |
| ▸ | NCOA2 | Q15596 | 2/20 | 0.67 |
| ▸ | NCOA1 | Q15788 | 2/20 | 0.67 |
| ▸ | NCOA3 | Q9Y6Q9 | 2/20 | 0.67 |
| ▸ | PRNP | P04156 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | RECQL | P46063 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 4/20 | 0.66 |
| ▸ | PLEC | Q15149 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16639849 | 0.87 | TP53 (0.75) | TP53MAPTLMNAMEN1KMT2A | |
| SCHEMBL16639761 | 0.79 | NAMPT (0.69) | TP53MAPTMEN1KMT2AKDM4E | |
| SCHEMBL31562878 | 0.78 | KMT2A (0.65) | TP53MAPTLMNAMEN1KMT2A | |
| SCHEMBL27312826 | 0.78 | KMT2A (0.65) | TP53MAPTLMNAMEN1KMT2A | |
| SCHEMBL16747245 | 0.77 | THRB (0.56) | TP53MAPTLMNARXFP1MEN1 | |
| SCHEMBL16644237 | 0.77 | MAPT (0.55) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL15246505 | 0.75 | MAPT (0.53) | MAPTLMNAMEN1KMT2AKDM4E | |
| SCHEMBL1156395 | 0.75 | TP53 (0.65) | TP53MAPTLMNAMEN1KMT2A | |
| SCHEMBL10293253 | 0.74 | TP53 (0.66) | TP53MAPTLMNAMEN1KMT2A | |
| SCHEMBL16639785 | 0.74 | GAA (0.55) | TP53MAPTMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10696692-B2 | Amido-benzyl sulfone and sulfoxide derivates | Valo Health, LLC | 2020-06-30 | — | — | US | disclosed |
| US-20150104384-A1 | AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES | VALO HEALTH, INC. | 2015-04-16 | — | — | US | disclosed |
| US-20150104384-A1 | AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES | VALO HEALTH, INC. | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10696692-B2 | Amido-benzyl sulfone and sulfoxide derivates | STS, SQOR, SULT1E1 | TP53 1915/4885MAPT 1118/4885LMNA 3203/4885 |
| US-20150104384-A1 | AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES | STS, SULT1E1, CBS | TP53 2268/4885MAPT 2018/4885LMNA 3476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.